Zhitong Finance App News, Yimai Sunshine (02522) announced that on April 26, 2026, the company, buyer Yimai Sunshine Medical Imaging (Hong Kong) Co., Ltd., seller 1 Sun Seeds Management Co., Limited and target company 1 Hong Kong Sun Seeds Management Co., Limited entered into a share purchase agreement 1. Based on this, the buyer plans to purchase the target share capital 1 (100% of target company 1's shares). The total cost is HK$185 million;

The company, buyer, and seller 2 Yongan Value 4 Limited Partnership Fund and target company 2 Wingon Medical Technology Co., Limited Yongan Medical Technology Co., Ltd. entered into a share purchase agreement 2. According to this, the buyer intends to purchase the target share capital 2 (100% of the target company 2's shares) at a total cost of HK$168 million. The price will be paid by the company paying the seller in consideration shares.

All prerequisites for the acquisition were fulfilled on August 27, 2026. The Company has transferred 5.736,500 treasury shares and allotted and issued 23.206 million new H shares to Seller 1 in accordance with the share purchase agreement, and distributed 26.2295 million new H shares to Seller 2 to pay the price. As a result, the acquisition was declared complete.

On the date of this announcement, the total number of issued shares of the Company increased to 450 million shares (including 107 million unlisted shares and 344 million H shares), and the Company does not hold any treasury shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.